Related Experiment Video
Updated: Jan 23, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION
Stefan Naydenov Naydenov1, Nikolay Margaritov Runev1, Emil Ivanov Manov1
11Prof. St. Kirkovich Department of Internal Diseases, Medical University of Sofia, Sofia, Bulgaria; 2Tokuda Hospital, Sofia, Bulgaria.
Insights
A single-pill combination of atorvastatin/amlodipine effectively managed arterial hypertension and dyslipidemia in high-risk patients. This treatment demonstrated significant reductions in blood pressure and cholesterol levels over three months with good tolerability.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Medicine
Background:
- Arterial hypertension and dyslipidemia are key risk factors for cardiovascular disease.
- Managing these conditions concurrently is crucial for reducing overall cardiovascular risk.
- A single-pill combination offers a simplified therapeutic approach.
Purpose of the Study:
- To assess the efficacy and tolerability of a fixed-dose combination of atorvastatin and amlodipine.
- To evaluate the impact of this combination therapy on blood pressure and lipid profiles.
- To determine the effectiveness in patients with moderate to high cardiovascular risk.
Main Methods:
- Prospective study involving 243 patients.
- Patients received atorvastatin/amlodipine in doses of 10/5, 10/10, 20/5, or 20/10 mg daily.
- Follow-up duration was 3 months.
Main Results:
- Significant reductions in systolic blood pressure (155.7 to 136.9 mm Hg) and diastolic blood pressure (92.0 to 80.6 mm Hg).
- Significant reductions in total cholesterol (6.6 to 5.1 mmol/L) and LDL cholesterol (4.4 to 2.9 mmol/L).
- Adverse events led to discontinuation in only 3.7% of patients.
Conclusions:
- The single-pill combination of atorvastatin/amlodipine is effective in treating patients with hypertension and dyslipidemia.
- This combination therapy is well-tolerated in patients at moderate to high cardiovascular risk.
- Simplified treatment regimens can improve adherence and outcomes in cardiovascular disease management.
Abstract:
- The aim was to evaluate the efficacy of a single-pill combination of atorvastatin/amlodipine in patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk. This prospective study included 243 patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk, mean age 63.3±9.8 years. All patients were prescribed a treatment with one of the following doses of a single-pill combination of atorvastatin/amlodipine: 10/5, 10/10, 20/5 or 20/10 mg daily. The follow-up period was 3 months. The mean baseline values of the systolic and diastolic blood pressure were 155.7±16.2 and 92.0±9.2 mm Hg, respectively. At month 3, the respective mean systolic and diastolic blood pressure values were 136.9±26.9 and 80.6±5.1 mm Hg. The mean baseline values of total cholesterol and low-density lipoprotein cholesterol were 6.6±1.2 and 4.4±1.1 mmol/L, respectively. At month 3, the respective mean values of total cholesterol and low-density lipoprotein cholesterol were 5.1±0.9 and 2.9±1.0 mmol/L. Treatment was discontinued in 9 (3.7%) patients due to adverse events. In conclusion, treatment with the single-pill combination of atorvastatin/amlodipine was effective and well tolerated by the patients with arterial hypertension, dyslipidemia and moderate to high cardiovascular risk.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Survey Safety
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Self-Efficacy

